MARKET

ASXC

ASXC

Asensus Surgical Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

2.100
+0.040
+1.94%
After Hours: 2.050 -0.05 -2.38% 19:59 04/13 EDT
OPEN
1.960
PREV CLOSE
2.060
HIGH
2.180
LOW
1.920
VOLUME
12.52M
TURNOVER
--
52 WEEK HIGH
6.95
52 WEEK LOW
0.3000
MARKET CAP
488.44M
P/E (TTM)
-1.8329
1D
5D
1M
3M
1Y
5Y
OGI, TLRY, APHA among premarket losers
Avenue Therapeutics (ATXI) -16% after FDA continues to review NDA for IV Tramadol.Lucira Health (LHDX) -12%.OrganiGram (OGI) -12% on FQ2 results.Zomedica (ZOM) -11%.Brooklyn ImmunoTherapeutics (BTX) -10%.Fortress Biotech (FBIO) -9%.Pintec Technology (PT) -...
Seekingalpha · 17h ago
Here's Why You Should Hold on to STERIS (STE) Stock Now
Zacks.com · 17h ago
ASXC, NUAN, CAN and EARS among midday movers
Gainers: Wilhelmina International (WHLM) +44%.180 Life Sciences (ATNF) +28%.Evelo Biosciences (EVLO) +24%.Celcuity (CELC) +19%.Taysha Gene Therapies (TSHA) +17%.Nuance Communications (NUAN) +16%.Tiziana Life Sciences (TLSA) +15%.PLBY Group (PLBY) +13%.Pint...
Seekingalpha · 1d ago
Abbott (ABT) Gets Europe Nod for TriClip G4 to Treat TR
Zacks.com · 1d ago
Hologic (HOLX) to Buy Mobidiag, Boost Diagnostics Testing Arm
Zacks.com · 1d ago
Is the Options Market Predicting a Spike in Asensus (ASXC) Stock?
Zacks.com · 4d ago
Quest Diagnostics (DGX) Rides on Test Sales Amid Volume Woe
Zacks.com · 04/06 13:56
Orthofix (OFIX) Wins FDA Clearance for CONSTRUX Mini Ti System
Zacks.com · 04/06 12:27
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ASXC. Analyze the recent business situations of Asensus Surgical Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ASXC stock price target is 1.450 with a high estimate of 1.450 and a low estimate of 1.450.
EPS
Institutional Holdings
Institutions: 157
Institutional Holdings: 73.36M
% Owned: 31.54%
Shares Outstanding: 232.59M
TypeInstitutionsShares
Increased
45
6.91M
New
19
2.21M
Decreased
31
11.32M
Sold Out
24
1.40M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.85%
Healthcare Equipment & Supplies
+1.78%
Key Executives
Chairman/Independent Director
Paul LaViolette
President/Chief Executive Officer/Director
Anthony Fernando
Chief Financial Officer/Executive Vice President
Shameze Rampertab
Independent Director
Andrea Biffi
Independent Director
Jane Hsiao
Independent Director
William Kelley
Independent Director
David Milne
Independent Director
Richard Pfenniger
Independent Director
William Starling
No Data
About ASXC
Asensus Surgical, Inc., formerly TransEnterix, Inc., is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. Its System is designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, advanced instrumentation, including three-millimeter micro laparoscopic instruments, eye-sensing camera control and reusable standard instruments to patients around the world. The Senhance System is used in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.

Webull offers kinds of Asensus Surgical Inc stock information, including AMEX:ASXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASXC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ASXC stock methods without spending real money on the virtual paper trading platform.